MedPath

Gestational Diabetes: Induction Versus Expectant Management of Labour

Not Applicable
Completed
Conditions
Diabetes Mellitus, Gestational
Diabetes, Pregnancy Induced
Gestational Diabetes
Gestational Diabetes Mellitus
Pregnancy-Induced Diabetes
Interventions
Other: INDUCTION of LABOUR
Registration Number
NCT01058772
Lead Sponsor
IRCCS Burlo Garofolo
Brief Summary

The purpose of this study is to determine whether, in Gestational Diabetes Mellitus (GDM) pregnancies, induction of labour at 38-39 weeks of pregnancy is superior to expectant management in terms of maternal and neonatal outcomes.

Detailed Description

Gestational Diabetes Mellitus (GDM) is one of the most common complications of pregnancy and its incidence is estimated as around 7%. Babies born from women with GDM are significantly more exposed to perinatal risk. Furthermore in GDM pregnancies an increased C-section rate has been observed, mostly unjustified.

Strong evidence, based on prospective studies and randomized controlled trials, in favour or against the effectiveness and safeness of induction in women with GDM, are missing. The aim of the present study is to identify the best management for these women at term and provide evidence that could change the current clinical practice.

To reach this objective, 1760 eligible women will be recruited at 9 Teaching Hospitals (5 in Italy, 4 all over the world). Sample size has been estimated to demonstrate a difference between the two arms ≥ 6% (31% of C-section in the expectant group and 25% in the induction group; relative difference between the 2 groups equal to 20% in favor of induction; Kjos et al, 1993), considering an α error equal to 5% and 80% power.

Patients will be randomized to induction of labour (N=880) or expectant management (N=880). Data on maternal and neonatal outcomes will be collected at delivery and until maternal and neonatal discharge.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
425
Inclusion Criteria
  • Maternal age > 18;
  • Singleton pregnancy in vertex presentation;
  • Gestational age between 38-39 weeks verified by LMP and first trimester ultrasound when available;
  • Women diagnosed with GDM in the current pregnancy [Diagnosis will be based upon abnormal 50 Gr. GCT (>140) followed by >2 abnormal indices in the OGTT (according to C&C criteria). Women with GCT>200 mg/dl will undergo 100 gr OGTT as well];
  • No other contraindications for vaginal delivery.
Exclusion Criteria
  • Pre-gestational diabetes;
  • Prior C-section;
  • Suspected estimated fetal weight> 4000 gr. at enrollment;
  • Any known contraindications for vaginal delivery;
  • Uncertain gestational age;
  • Non-reassuring fetal status necessitating immediate obstetrical intervention (prompt delivery/prompt C-section);
  • Maternal disease complicating pregnancy and necessitating delivery (e.g Severe PET);
  • Bishop score >7 at enrollment;
  • Major fetal malformation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
INDUCTION of LABOURINDUCTION of LABOURAt enrollment patients assigned to the induction group will be admitted to the obstetric ward and will undergo induction of labour as described in the intervention section. Once patient's Bishop score exceeds 7 or regular contractions are diagnosed, patients will be transferred to the delivery ward for artificial rupture of membranes (ARM) or Oxytocin augmentation as indicated.
Primary Outcome Measures
NameTimeMethod
C-section rate1 minute after delivery
Secondary Outcome Measures
NameTimeMethod
Shoulder Dystociaduring delivery
Operative Vaginal Delivery1 minute after delivery
Perineal Tears or Episiotomy1 minute after delivery
Postpartum haemorrhagewithin 24 hours from delivery
Maternal Blood Transfusionuntil maternal discharge
Maternal Intensive Care Unit Admissionuntil maternal discharge
Neonatal Weight10 minutes after delivery
Neonatal Apgar score at 1', 5', 10' minutes1, 5, 10 minutes after delivery
Manoeuvres for Shoulder Dystociaduring delivery
Neonatal Intensive Care Unit Admissionuntil neonatal discharge
Arterial cord Ph inferior to 7.2within 5 minutes from delivery
Neonatal Hyperbilirubinemiauntil neonatal discharge
Clinical and Biochemical Neonatal Hypoglycemiauntil neonatal discharge
Neonatal Polycythemiauntil neonatal discharge
Neonatal Birth Trauma10 minute from delivery or until neonatal discharge
Neonatal Respiratory Distress/Transient Tachypneauntil neonatal discharge
Neonatal Need for Respiratory Supportuntil neonatal discharge
Maternal deathuntil neonatal discharge
Perinatal Deathuntil neonatal discharge
Spontaneous/Instrumental third stage of labourwithin 1 hours from delivery
Indication for Cesarean Section1 minutes after delivery

Trial Locations

Locations (9)

Helen Schneider's Hospital for Women - Rabin Medical Center

🇮🇱

Petah-Tiqva, Israel

I Ostetricia Spedali Civili

🇮🇹

Brescia, Italy

Department of Gynecology Perinatology and Human Reproduction

🇮🇹

Florence, Italy

Unità Operativa di Ostetricia e Ginecologia - Ospedale Buzzi

🇮🇹

Milan, Italy

Department of Obstetrics and Gynecology - University of Colombo

🇱🇰

Colombo, Sri Lanka

Institute for Maternal and Child Health - IRCCS Burlo Garofolo

🇮🇹

Trieste, Italy

Dipartimento di Discipline Ginecologiche ed Ostetriche - Università di Torino

🇮🇹

Turin, Italy

Division Woman and Baby - UMC Utrecht/ Wilhelmina Children's Hospital

🇳🇱

Utrecht, Netherlands

Department of ob/gyn, Division of perinatology - University Medical Centre

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath